Impact of antimicrobial stewardship implementation on the antibiotic use and susceptibility in a Japanese long-term care hospital

Antimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been pointed out to be important reservoirs for AMR. However, evidence illustrating the association between AMU and AMR in LTCHs is lacking compared...

Full description

Saved in:
Bibliographic Details
Published inJournal of Infection and Chemotherapy Vol. 30; no. 2; pp. 134 - 140
Main Authors Kurabayashi, Makoto, Yamada, Takehiro, Tomita, Masashi, Matsumoto, Minami, Mizutani, Ryunosuke, Uesugi, Koichi, Niino, Hideki, Yamada, Hidetoshi, Isobe, Takeshi, Edagawa, Shunji
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.02.2024
Elsevier BV
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Antimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been pointed out to be important reservoirs for AMR. However, evidence illustrating the association between AMU and AMR in LTCHs is lacking compared to that of acute care hospitals. We evaluated the impact of an antimicrobial stewardship (AS) program implementation, in a LTCH on AMU and antibiotic susceptibility between three periods: the pre-AS-period (pre-AS); the first period after AS implementation (post-AS 1), in which initiated recommendation the blood culture collection and definitive therapy by AS team; and the second period (post-AS 2), implementation of a balanced use of antibiotics was added. After the AS implementation, a significant increase in the number of blood cultures collected was observed. Conversely, the AMU of piperacillin-tazobactam (PIPC/TAZ), which has activity against Pseudomonas aeruginosa, was increased and occupied 43.0% of all injectable AMU in post-AS 1 compared with that in pre-AS (35.5%). In the post-AS 2 period, we analyzed the %AUD and recommended hospital-wide PIPC/TAZ sparing; this resulted in the significant reduction in %AUD of PIPC/TAZ, which was associated with improved susceptibility of P. aeruginosa to PIPC/TAZ. These results suggest that AS programs aimed at implementing antibiotic sparing may lead to improve AMR, highlighting the necessity of correcting overuse of a single class of antibiotics and usefulness of AMU monitoring in the LTCH setting.
AbstractList Antimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been pointed out to be important reservoirs for AMR. However, evidence illustrating the association between AMU and AMR in LTCHs is lacking compared to that of acute care hospitals. We evaluated the impact of an antimicrobial stewardship (AS) program implementation, in a LTCH on AMU and antibiotic susceptibility between three periods: the pre-AS-period (pre-AS); the first period after AS implementation (post-AS 1), in which initiated recommendation the blood culture collection and definitive therapy by AS team; and the second period (post-AS 2), implementation of a balanced use of antibiotics was added. After the AS implementation, a significant increase in the number of blood cultures collected was observed. Conversely, the AMU of piperacillin-tazobactam (PIPC/TAZ), which has activity against Pseudomonas aeruginosa, was increased and occupied 43.0% of all injectable AMU in post-AS 1 compared with that in pre-AS (35.5%). In the post-AS 2 period, we analyzed the %AUD and recommended hospital-wide PIPC/TAZ sparing; this resulted in the significant reduction in %AUD of PIPC/TAZ, which was associated with improved susceptibility of P. aeruginosa to PIPC/TAZ. These results suggest that AS programs aimed at implementing antibiotic sparing may lead to improve AMR, highlighting the necessity of correcting overuse of a single class of antibiotics and usefulness of AMU monitoring in the LTCH setting.
Antimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been pointed out to be important reservoirs for AMR. However, evidence illustrating the association between AMU and AMR in LTCHs is lacking compared to that of acute care hospitals.BACKGROUNDAntimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been pointed out to be important reservoirs for AMR. However, evidence illustrating the association between AMU and AMR in LTCHs is lacking compared to that of acute care hospitals.We evaluated the impact of an antimicrobial stewardship (AS) program implementation, in a LTCH on AMU and antibiotic susceptibility between three periods: the pre-AS-period (pre-AS); the first period after AS implementation (post-AS 1), in which initiated recommendation the blood culture collection and definitive therapy by AS team; and the second period (post-AS 2), implementation of a balanced use of antibiotics was added.METHODSWe evaluated the impact of an antimicrobial stewardship (AS) program implementation, in a LTCH on AMU and antibiotic susceptibility between three periods: the pre-AS-period (pre-AS); the first period after AS implementation (post-AS 1), in which initiated recommendation the blood culture collection and definitive therapy by AS team; and the second period (post-AS 2), implementation of a balanced use of antibiotics was added.After the AS implementation, a significant increase in the number of blood cultures collected was observed. Conversely, the AMU of piperacillin-tazobactam (PIPC/TAZ), which has activity against Pseudomonas aeruginosa, was increased and occupied 43.0% of all injectable AMU in post-AS 1 compared with that in pre-AS (35.5%). In the post-AS 2 period, we analyzed the %AUD and recommended hospital-wide PIPC/TAZ sparing; this resulted in the significant reduction in %AUD of PIPC/TAZ, which was associated with improved susceptibility of P. aeruginosa to PIPC/TAZ.RESULTSAfter the AS implementation, a significant increase in the number of blood cultures collected was observed. Conversely, the AMU of piperacillin-tazobactam (PIPC/TAZ), which has activity against Pseudomonas aeruginosa, was increased and occupied 43.0% of all injectable AMU in post-AS 1 compared with that in pre-AS (35.5%). In the post-AS 2 period, we analyzed the %AUD and recommended hospital-wide PIPC/TAZ sparing; this resulted in the significant reduction in %AUD of PIPC/TAZ, which was associated with improved susceptibility of P. aeruginosa to PIPC/TAZ.These results suggest that AS programs aimed at implementing antibiotic sparing may lead to improve AMR, highlighting the necessity of correcting overuse of a single class of antibiotics and usefulness of AMU monitoring in the LTCH setting.CONCLUSIONSThese results suggest that AS programs aimed at implementing antibiotic sparing may lead to improve AMR, highlighting the necessity of correcting overuse of a single class of antibiotics and usefulness of AMU monitoring in the LTCH setting.
Author Mizutani, Ryunosuke
Yamada, Hidetoshi
Isobe, Takeshi
Matsumoto, Minami
Edagawa, Shunji
Niino, Hideki
Uesugi, Koichi
Kurabayashi, Makoto
Yamada, Takehiro
Tomita, Masashi
Author_xml – sequence: 1
  givenname: Makoto
  surname: Kurabayashi
  fullname: Kurabayashi, Makoto
  email: kurabayashi-ma@keijinkai.or.jp
  organization: Department of Pharmacy, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan
– sequence: 2
  givenname: Takehiro
  surname: Yamada
  fullname: Yamada, Takehiro
  email: yamada-t@hus.ac.jp
  organization: Department of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 15-4-1, Maeda 7-jo, Teine-ku, Sapporo, 006-8585, Japan
– sequence: 3
  givenname: Masashi
  surname: Tomita
  fullname: Tomita, Masashi
  email: tomita-m@keijinkai.or.jp
  organization: Department of Pharmacy, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan
– sequence: 4
  givenname: Minami
  surname: Matsumoto
  fullname: Matsumoto, Minami
  email: nishimaruyama-di@keijinkai.or.jp
  organization: Department of Pharmacy, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan
– sequence: 5
  givenname: Ryunosuke
  surname: Mizutani
  fullname: Mizutani, Ryunosuke
  email: 117a157@stu.hus.ac.jp
  organization: Department of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 15-4-1, Maeda 7-jo, Teine-ku, Sapporo, 006-8585, Japan
– sequence: 6
  givenname: Koichi
  surname: Uesugi
  fullname: Uesugi, Koichi
  email: u-06koichi@asahikawa-med.ac.jp
  organization: Department of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 15-4-1, Maeda 7-jo, Teine-ku, Sapporo, 006-8585, Japan
– sequence: 7
  givenname: Hideki
  surname: Niino
  fullname: Niino, Hideki
  email: niino-hi@keijinkai.or.jp
  organization: Department of Infection Control and Prevention, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan
– sequence: 8
  givenname: Hidetoshi
  surname: Yamada
  fullname: Yamada, Hidetoshi
  email: h-yamada.0725_pharm@keijinkai.or.jp
  organization: Department of Pharmacy, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan
– sequence: 9
  givenname: Takeshi
  surname: Isobe
  fullname: Isobe, Takeshi
  email: isobe-ta@keijinkai.or.jp
  organization: Department of Infection Control and Prevention, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan
– sequence: 10
  givenname: Shunji
  orcidid: 0000-0001-7336-0734
  surname: Edagawa
  fullname: Edagawa, Shunji
  email: edagawa-sh@keijinkai.or.jp
  organization: Department of Infection Control and Prevention, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan
BackLink https://cir.nii.ac.jp/crid/1873116918005159296$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/37793545$$D View this record in MEDLINE/PubMed
BookMark eNp9kU2P1SAUhokZ43zoH3BhWLhw084BSinuzETHMZPMZkzcEUrBy5WWWqjmLv3n0rmjy0nIAU6e85H3PUcnU5wsQq8J1ARIe7mv916bmgJlNcgaqHyGzkjDRCVEByflzRpSMUq-naLzlPYARPCue4FOmRCS8YafoT8346xNxtFhPWU_erPE3uuAU7a_9TKknZ-xH-dgRztlnX2ccDl5Zx_43sfsDV7T9h1wWpOx85YOPh-wn7DGX_SsJ1uAEKfvVbbLiI1eLN7FNPusw0v03OmQ7KvH-wJ9_fTx_upzdXt3fXP14bYyjRC5co7DQPuBQG-gZ65hTmjgRpuGUsE0ZYMz1IDshW5akI7THpwExzhr-0ayC_Tu2Hde4s_VpqxGX7YNoWwX16RoJxjltANS0DeP6NqPdlDz4ke9HNQ_2QpAj0BRK6XFuv8IAbV5o_Zq80Zt3iiQqnhTit4eiybvlfFbJGUmIa0kHQAnXFLZFuz9EbNFjF_eLsqEAhsdftiDGqJ_asZfbIai6A
Cites_doi 10.1155/2022/2497869
10.1016/j.jhin.2009.11.022
10.1038/bmt.2012.244
10.1016/S1473-3099(13)70195-6
10.1378/chest.115.5.1378
10.2807/1560-7917.ES.2018.23.46.1800100
10.3390/pharmaceutics15020518
10.1016/S1473-3099(20)30477-1
10.2807/1560-7917.ES.2018.23.46.1800394
10.1186/s12879-021-06939-2
10.1016/j.archger.2020.104220
10.1093/jac/dkz008
10.1016/j.ajic.2018.06.019
10.2807/1560-7917.ES.23.46.1800393
10.1248/bpb.b15-00797
10.1016/j.jiac.2019.05.026
10.1111/j.1469-0691.2005.01238.x
10.1016/j.jhin.2018.11.018
10.3390/antibiotics10060680
10.1002/hep.510290406
10.1371/journal.pone.0208039
ContentType Journal Article
Copyright 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control
Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control
– notice: Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.
DBID RYH
AAYXX
CITATION
NPM
7X8
DOI 10.1016/j.jiac.2023.09.029
DatabaseName CiNii Complete
CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1437-7780
EndPage 140
ExternalDocumentID 37793545
10_1016_j_jiac_2023_09_029
S1341321X23002398
Genre Journal Article
GroupedDBID ---
--M
-Y2
-~C
.1-
.55
.86
.FO
.~1
0R~
0VY
1N0
1P~
1SB
1~.
2.D
28-
29K
2JY
2P1
2VQ
2~H
30V
4.4
408
409
40D
457
4G.
53G
5GY
5QI
5VS
67Z
6NX
7-5
8P~
8TC
8UJ
95.
95~
AAAJQ
AAEDT
AAEDW
AAIAL
AAIKJ
AAKOC
AALRI
AANXM
AAOAW
AAQFI
AARHV
AATTM
AAXKI
AAXUO
AAYWO
AAYZH
ABFSG
ABJNI
ABMAC
ABMNI
ABMZM
ABQSL
ABXDB
ACDAQ
ACGFS
ACIEU
ACOMO
ACRLP
ACSTC
ACVFH
ADBBV
ADCNI
ADEZE
ADHKG
ADIMF
ADKPE
ADQRH
ADRFC
ADVLN
AEBSH
AEFIE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEZWR
AFBBN
AFEXP
AFHIU
AFLOW
AFPUW
AFRHN
AFTJW
AFWTZ
AFXIZ
AGCQF
AGGDS
AGHFR
AGJBK
AGQPQ
AGUBO
AHBYD
AHKAY
AHSBF
AHWEU
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AIXLP
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMRAJ
ANKPU
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BA0
BBWZM
BGNMA
BKOJK
BLXMC
BNPGV
CAG
CJTIS
COF
CS3
CSCUP
D-I
DL5
EBS
EFJIC
EFKBS
EJD
EMOBN
EN4
F5P
FDB
FEDTE
FIRID
FYGXN
GBLVA
GQ8
GXS
H13
HF~
HG5
HG6
HMJXF
HVGLF
HZ~
I09
IHE
IXC
IXE
IZIGR
IZQ
I~X
KDC
KOM
KOW
KPH
LAS
M41
M4Y
MA-
MO0
N2Q
N9A
NB0
NDZJH
NU0
O9-
O93
O9G
O9I
OAM
OAUVE
OC~
P-8
P-9
P19
P2P
P9S
PC.
PT5
QOK
QOS
R4E
R89
R9I
RNI
ROL
RPX
RRX
RSV
RZK
S1Z
S26
S27
S28
S37
S3B
SDE
SDH
SDM
SMD
SOJ
SPCBC
SSH
SSZ
SV3
T13
T16
T5K
TSK
TSV
TT1
TUC
U2A
VC2
WJK
WK8
X7M
Z45
Z5R
~A9
~EX
~G-
AFCTW
AGRNS
RYH
SSI
AAYXX
ABTEG
CITATION
RIG
-5E
-5G
-BR
0SF
AACTN
ADINQ
AFKWA
AJOXV
AMFUW
GQ6
NCXOZ
NPM
SZN
Z7U
Z82
Z87
Z8O
Z8V
Z91
7X8
ID FETCH-LOGICAL-c477t-ff50d2bd10bc0b3f43f7a05cac42273a23dfc2c09b7a4609f52b0f90f3536b493
ISSN 1341-321X
1437-7780
IngestDate Mon Jul 21 10:10:45 EDT 2025
Wed Feb 19 02:08:39 EST 2025
Tue Jul 01 02:23:41 EDT 2025
Thu Jun 26 22:05:55 EDT 2025
Tue Aug 26 18:42:30 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords AHI
Antibiotic sparing
PIPC/TAZ
DDD
CTRX
AMU
GNRs
Antimicrobial resistant
IQR
LTCHs
ATC
MEPM
AS
PPS
CPZ/SBT
Antimicrobial stewardship
ICT
ASP
Language English
License Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c477t-ff50d2bd10bc0b3f43f7a05cac42273a23dfc2c09b7a4609f52b0f90f3536b493
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7336-0734
PMID 37793545
PQID 2873252801
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_2873252801
pubmed_primary_37793545
crossref_primary_10_1016_j_jiac_2023_09_029
nii_cinii_1873116918005159296
elsevier_clinicalkey_doi_10_1016_j_jiac_2023_09_029
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2024
2024-02-01
2024-02-00
2024-Feb
20240201
PublicationDateYYYYMMDD 2024-02-01
PublicationDate_xml – month: 02
  year: 2024
  text: February 2024
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Journal of Infection and Chemotherapy
PublicationTitleAlternate J Infect Chemother
PublicationYear 2024
Publisher Elsevier Ltd
Elsevier BV
Publisher_xml – name: Elsevier Ltd
– name: Elsevier BV
References Tabak, Sung, Ye, Vankeepuram, Gupta, McCann (bib3) 2019; 102
Murayama, Kobayashi, Okamoto, Fukaya, Ishizaki, Liang (bib6) 2020; 91
Plachouras, Karki, Hansen, Hopkins, Lyytikainen, Moro (bib22) 2018; 23
Ricchizzi, Latour, Kärki, Buttazzi, Jans, Moro (bib23) 2018; 23
Niwa, Watanabe, Goto, Ohta, Nakayama, Suzuki (bib13) 2016; 39
(bib15) 2017
Madrazo, Esparcia, López-Cruz, Alberola, Piles, Viana (bib8) 2021; 21
Hattori, Maeda, Nagatomo, Takuma, Niki, Naito (bib11) 2018; 46
Tan, Guzman, Donato, Kalimuddin, Lee, Tan (bib19) 2018 Nov 28; 13
Ishibashi, Pauwels, Tomori, Gu, Yamaguchi, Handa (bib24) 2022
[accessed 10 February, 2021].
Stepan, Usaj, Ster, Galun, Smole, Bevoc (bib5) 2018; 23
Peterson (bib21) 2005; 11
Kanda (bib16) 2013; 48
Takesue, Nakajima, Ichiki, Ishihara, Wada, Takahashi (bib10) 2010; 75
Howard, Catchpole, Watson, Davies (bib1) 2013; 13
World Health Organization. ATC/DDD index 2021. Collaborating Centre for Drug Statistics Methodology
Husni, Goldstein, Arroliga, Hall, Fatica, Stoller (bib18) 1999; 115
Thornley, Ashiru-Oredope, Normington, Beech, Howard (bib7) 2019; 74
Ortiz, Vila, Soriano, Miñana, Gana, Mirelis (bib17) 1999; 29
[accessed 21 April, 2022].
Ueda, Takesue, Nakajima, Ichiki, Ishikawa, Yamada (bib20) 2023; 15
Ministry of Health. Labor and Welfare. National action plan on antimicrobial resistance
Kadri, Lai, Warner, Strich, Babiker, Ricotta (bib2) 2021; 21
Rodríguez-Villodres, Martín-Gandul, Peñalva, Guisado-Gil, Crespo-Rivas, Pachón-Ibáñez (bib9) 2021; 10
Yamada, Imoto, Yamairi, Shibata, Namikawa, Yoshii (bib12) 2019; 25
Rodríguez-Villodres (10.1016/j.jiac.2023.09.029_bib9) 2021; 10
Kadri (10.1016/j.jiac.2023.09.029_bib2) 2021; 21
Madrazo (10.1016/j.jiac.2023.09.029_bib8) 2021; 21
Niwa (10.1016/j.jiac.2023.09.029_bib13) 2016; 39
Ricchizzi (10.1016/j.jiac.2023.09.029_bib23) 2018; 23
Ishibashi (10.1016/j.jiac.2023.09.029_bib24) 2022
Plachouras (10.1016/j.jiac.2023.09.029_bib22) 2018; 23
Husni (10.1016/j.jiac.2023.09.029_bib18) 1999; 115
Yamada (10.1016/j.jiac.2023.09.029_bib12) 2019; 25
Howard (10.1016/j.jiac.2023.09.029_bib1) 2013; 13
Stepan (10.1016/j.jiac.2023.09.029_bib5) 2018; 23
Peterson (10.1016/j.jiac.2023.09.029_bib21) 2005; 11
10.1016/j.jiac.2023.09.029_bib4
Ortiz (10.1016/j.jiac.2023.09.029_bib17) 1999; 29
Ueda (10.1016/j.jiac.2023.09.029_bib20) 2023; 15
Kanda (10.1016/j.jiac.2023.09.029_bib16) 2013; 48
Thornley (10.1016/j.jiac.2023.09.029_bib7) 2019; 74
Takesue (10.1016/j.jiac.2023.09.029_bib10) 2010; 75
10.1016/j.jiac.2023.09.029_bib14
Tabak (10.1016/j.jiac.2023.09.029_bib3) 2019; 102
Tan (10.1016/j.jiac.2023.09.029_bib19) 2018; 13
Murayama (10.1016/j.jiac.2023.09.029_bib6) 2020; 91
Hattori (10.1016/j.jiac.2023.09.029_bib11) 2018; 46
(10.1016/j.jiac.2023.09.029_bib15) 2017
References_xml – year: 2022
  ident: bib24
  article-title: Point prevalence surveys of antimicrobial prescribing in a non-acute care hospital in Saitama Prefecture, Japan
  publication-title: Can J Infect Dis Med Microbiol
– volume: 46
  start-page: e75
  year: 2018
  end-page: e79
  ident: bib11
  article-title: Epidemiology and risk factors for mortality in bloodstream infections: a single-center retrospective study in Japan
  publication-title: Am J Infect Control
– volume: 102
  start-page: 37
  year: 2019
  end-page: 44
  ident: bib3
  article-title: Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections
  publication-title: J Hosp Infect
– volume: 23
  year: 2018
  ident: bib23
  article-title: Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
  publication-title: Euro Surveill
– reference: Ministry of Health. Labor and Welfare. National action plan on antimicrobial resistance,
– volume: 13
  start-page: 1001
  year: 2013
  end-page: 1003
  ident: bib1
  article-title: Antibiotic resistance: global response needed
  publication-title: Lancet Infect Dis
– volume: 21
  start-page: 241
  year: 2021
  end-page: 251
  ident: bib2
  article-title: Forming the national institutes of health antimicrobial resistance outcomes research initiative (NIH-ARORI)
  publication-title: Lancet Infect Dis
– volume: 10
  start-page: 680
  year: 2021
  ident: bib9
  article-title: Prevalence and risk factors for multidrug-resistant organisms colonization in long-term care facilities around the world: a review
  publication-title: Antibiotics
– reference: , [accessed 21 April, 2022].
– volume: 39
  start-page: 721
  year: 2016
  end-page: 727
  ident: bib13
  article-title: Daily review of antimicrobial use facilitates the early optimization of antimicrobial therapy and improves clinical outcomes of patients with bloodstream infections
  publication-title: Biol Pharm Bull
– reference: , [accessed 10 February, 2021].
– volume: 91
  year: 2020
  ident: bib6
  article-title: National prevalence of frailty in the older Japanese population: findings from a nationally representative survey
  publication-title: Arch Gerontol Geriatr
– volume: 11
  start-page: 4
  year: 2005
  end-page: 16
  ident: bib21
  article-title: Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance
  publication-title: Clin Microbiol Infect
– volume: 23
  year: 2018
  ident: bib5
  article-title: Antimicrobial prescribing in long-term care facilities: a nationwide point-prevalence study, Slovenia, 2016
  publication-title: Euro Surveill
– volume: 74
  start-page: 1447
  year: 2019
  end-page: 1451
  ident: bib7
  article-title: Antibiotic prescribing for residents in long-term-care facilities across the UK
  publication-title: J Antimicrob Chemother
– volume: 13
  year: 2018 Nov 28
  ident: bib19
  article-title: Impact of an alternating first-line antibiotics strategy in febrile neutropenia
  publication-title: PLoS One
– volume: 23
  year: 2018
  ident: bib22
  article-title: The Point Prevalence Survey Study Group. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016-2017
  publication-title: Euro Surveill
– reference: World Health Organization. ATC/DDD index 2021. Collaborating Centre for Drug Statistics Methodology,
– volume: 15
  start-page: 518
  year: 2023
  ident: bib20
  article-title: Correlation between antimicrobial resistance and the hospital-wide diverse use of broad-spectrum antibiotics by the antimicrobial stewardship program in Japan
  publication-title: Pharmaceutics
– volume: 25
  start-page: 1001
  year: 2019
  end-page: 1006
  ident: bib12
  article-title: The intervention by antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria
  publication-title: J Infect Chemother
– volume: 29
  start-page: 1064
  year: 1999
  end-page: 1069
  ident: bib17
  article-title: Infections caused by E. coli resistant to norfloxacin in hospitalized cirrhotic patients
  publication-title: Hepatology
– volume: 48
  start-page: 452
  year: 2013
  end-page: 458
  ident: bib16
  article-title: Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
  publication-title: Bone Marrow Transplant
– volume: 75
  start-page: 28
  year: 2010
  end-page: 32
  ident: bib10
  article-title: Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria
  publication-title: J Hosp Infect
– volume: 21
  start-page: 1232
  year: 2021
  ident: bib8
  article-title: Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection
  publication-title: BMC Infect Dis
– year: 2017
  ident: bib15
  article-title: Performance standards for antimicrobial susceptibility testing
– volume: 115
  start-page: 1378
  year: 1999
  end-page: 1382
  ident: bib18
  article-title: Risk factors for an outbreak of multidrug-resistant Acinetobacter nosocomial pneumonia among intubated patients
  publication-title: Chest
– year: 2022
  ident: 10.1016/j.jiac.2023.09.029_bib24
  article-title: Point prevalence surveys of antimicrobial prescribing in a non-acute care hospital in Saitama Prefecture, Japan
  publication-title: Can J Infect Dis Med Microbiol
  doi: 10.1155/2022/2497869
– volume: 75
  start-page: 28
  year: 2010
  ident: 10.1016/j.jiac.2023.09.029_bib10
  article-title: Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria
  publication-title: J Hosp Infect
  doi: 10.1016/j.jhin.2009.11.022
– volume: 48
  start-page: 452
  year: 2013
  ident: 10.1016/j.jiac.2023.09.029_bib16
  article-title: Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
  publication-title: Bone Marrow Transplant
  doi: 10.1038/bmt.2012.244
– volume: 13
  start-page: 1001
  year: 2013
  ident: 10.1016/j.jiac.2023.09.029_bib1
  article-title: Antibiotic resistance: global response needed
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(13)70195-6
– volume: 115
  start-page: 1378
  year: 1999
  ident: 10.1016/j.jiac.2023.09.029_bib18
  article-title: Risk factors for an outbreak of multidrug-resistant Acinetobacter nosocomial pneumonia among intubated patients
  publication-title: Chest
  doi: 10.1378/chest.115.5.1378
– ident: 10.1016/j.jiac.2023.09.029_bib4
– volume: 23
  year: 2018
  ident: 10.1016/j.jiac.2023.09.029_bib5
  article-title: Antimicrobial prescribing in long-term care facilities: a nationwide point-prevalence study, Slovenia, 2016
  publication-title: Euro Surveill
  doi: 10.2807/1560-7917.ES.2018.23.46.1800100
– volume: 15
  start-page: 518
  year: 2023
  ident: 10.1016/j.jiac.2023.09.029_bib20
  article-title: Correlation between antimicrobial resistance and the hospital-wide diverse use of broad-spectrum antibiotics by the antimicrobial stewardship program in Japan
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics15020518
– volume: 21
  start-page: 241
  year: 2021
  ident: 10.1016/j.jiac.2023.09.029_bib2
  article-title: Forming the national institutes of health antimicrobial resistance outcomes research initiative (NIH-ARORI)
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(20)30477-1
– year: 2017
  ident: 10.1016/j.jiac.2023.09.029_bib15
– volume: 23
  year: 2018
  ident: 10.1016/j.jiac.2023.09.029_bib23
  article-title: Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
  publication-title: Euro Surveill
  doi: 10.2807/1560-7917.ES.2018.23.46.1800394
– volume: 21
  start-page: 1232
  year: 2021
  ident: 10.1016/j.jiac.2023.09.029_bib8
  article-title: Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection
  publication-title: BMC Infect Dis
  doi: 10.1186/s12879-021-06939-2
– ident: 10.1016/j.jiac.2023.09.029_bib14
– volume: 91
  year: 2020
  ident: 10.1016/j.jiac.2023.09.029_bib6
  article-title: National prevalence of frailty in the older Japanese population: findings from a nationally representative survey
  publication-title: Arch Gerontol Geriatr
  doi: 10.1016/j.archger.2020.104220
– volume: 74
  start-page: 1447
  year: 2019
  ident: 10.1016/j.jiac.2023.09.029_bib7
  article-title: Antibiotic prescribing for residents in long-term-care facilities across the UK
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkz008
– volume: 46
  start-page: e75
  year: 2018
  ident: 10.1016/j.jiac.2023.09.029_bib11
  article-title: Epidemiology and risk factors for mortality in bloodstream infections: a single-center retrospective study in Japan
  publication-title: Am J Infect Control
  doi: 10.1016/j.ajic.2018.06.019
– volume: 23
  year: 2018
  ident: 10.1016/j.jiac.2023.09.029_bib22
  article-title: The Point Prevalence Survey Study Group. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016-2017
  publication-title: Euro Surveill
  doi: 10.2807/1560-7917.ES.23.46.1800393
– volume: 39
  start-page: 721
  year: 2016
  ident: 10.1016/j.jiac.2023.09.029_bib13
  article-title: Daily review of antimicrobial use facilitates the early optimization of antimicrobial therapy and improves clinical outcomes of patients with bloodstream infections
  publication-title: Biol Pharm Bull
  doi: 10.1248/bpb.b15-00797
– volume: 25
  start-page: 1001
  year: 2019
  ident: 10.1016/j.jiac.2023.09.029_bib12
  article-title: The intervention by antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria
  publication-title: J Infect Chemother
  doi: 10.1016/j.jiac.2019.05.026
– volume: 11
  start-page: 4
  year: 2005
  ident: 10.1016/j.jiac.2023.09.029_bib21
  article-title: Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2005.01238.x
– volume: 102
  start-page: 37
  year: 2019
  ident: 10.1016/j.jiac.2023.09.029_bib3
  article-title: Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections
  publication-title: J Hosp Infect
  doi: 10.1016/j.jhin.2018.11.018
– volume: 10
  start-page: 680
  year: 2021
  ident: 10.1016/j.jiac.2023.09.029_bib9
  article-title: Prevalence and risk factors for multidrug-resistant organisms colonization in long-term care facilities around the world: a review
  publication-title: Antibiotics
  doi: 10.3390/antibiotics10060680
– volume: 29
  start-page: 1064
  year: 1999
  ident: 10.1016/j.jiac.2023.09.029_bib17
  article-title: Infections caused by E. coli resistant to norfloxacin in hospitalized cirrhotic patients
  publication-title: Hepatology
  doi: 10.1002/hep.510290406
– volume: 13
  issue: 11
  year: 2018
  ident: 10.1016/j.jiac.2023.09.029_bib19
  article-title: Impact of an alternating first-line antibiotics strategy in febrile neutropenia
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0208039
SSID ssj0017588
ssib050995435
ssib002821768
ssib058493233
Score 2.3498135
Snippet Antimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been...
SourceID proquest
pubmed
crossref
nii
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 134
SubjectTerms Antibiotic sparing
Antimicrobial resistant
Antimicrobial stewardship
Title Impact of antimicrobial stewardship implementation on the antibiotic use and susceptibility in a Japanese long-term care hospital
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1341321X23002398
https://cir.nii.ac.jp/crid/1873116918005159296
https://www.ncbi.nlm.nih.gov/pubmed/37793545
https://www.proquest.com/docview/2873252801
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLXYeOEFcaeMISOhvWSpEjuX5hEh0DZUtIcOjSfLdmrmbk2mJX0oD0j8cz7buRUoN6mK2ih1o5xT-9g-3_ch9IrAGCzCUPqhFJkfzbPE55kwToBJEuQRlzw3O7rTD8nRWXRyHp_32wU2uqQWY_nll3El_4MqnANcTZTsPyDbNQon4D3gC0dAGI5_hfFxH-JY1HqpbVIlGwAyN2ZYa8TSy9Yh7rShszWa64UuTbbWVeV2EKpVZS0u1i1rowG5dwJDqSlR6V2VxWff9OI2lbV30VQb2SJtjxuHlzM6m5wETZzXwHJ8WYLqfb8yloK1KejULyFczi_0Tel94kveLxdMeWWu8mblUtf9WV3wpfamvIbHDg0O1zBI1Nqe24W1Lrjm46ArhvHVp8QW1On66mYPx3W2YbMM6sbt0KV9-mlIcKsTi_FCc5OyklCb15ZkO-g2gamFqXox_roRyxsOpmCgp7J4IClBr4Hipd1oD-rL1jbt7rYJzHIewh9_c5v42Sm03j7FsVJndg_dbYDErx3h7qNbC_4AHZy6JOfrQzzrY_aqQ3yAT_v05-uH6JtjJS4V3mAlHrASb7ISwwsIgntWYmAlfMzxJiuxLjDHLStxx0psWIlbVj5CZ-_ezt4c-U2hD19GaVr7SsVBTkQeBkIGgqqIqpQHseQyIiCvOaG5kkQGmUh5lASZiokIVBYoGtNEACCP0W5RFvOnCNNEgkDPBEkFBQ0A0xNFcgkqLMlzoZJ0hLwWAXbt8rmw1ui4YAYvZvBiQcYArxGiLUisjVSGsZUBt377rX3Ak0ltjuEkpaHJSDWx5ZRgNpKM0MsWaQadudmhg6dWripG4GISE1CNI_TEUaC7S5MZlMJ859kfWt9Dd_q_2HO0W9-s5vsgnGvxwjL9O0ZMw4E
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+antimicrobial+stewardship+implementation+on+the+antibiotic+use+and+susceptibility+in+a+Japanese+long-term+care+hospital&rft.jtitle=Journal+of+Infection+and+Chemotherapy&rft.au=Makoto+Kurabayashi&rft.au=Takehiro+Yamada&rft.au=Masashi+Tomita&rft.au=Minami+Matsumoto&rft.date=2024-02-01&rft.pub=Elsevier+BV&rft.issn=1341-321X&rft.volume=30&rft.spage=134&rft.epage=140&rft_id=info:doi/10.1016%2Fj.jiac.2023.09.029
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-321X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-321X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-321X&client=summon